Followers | 4 |
Posts | 243 |
Boards Moderated | 0 |
Alias Born | 05/31/2008 |
Wednesday, March 21, 2012 3:59:08 PM
Seaside is not required to sell any stock. According to the contract with NNVC they only have to buy $400,000 of stock every other Wednesday.
So it is a matter of speculation as to how many shares Seaside actually sells. I investigated the types of companies that seaside has been investing (?) in. The result showed that they have this type of contract with companies in multiple industries, some even on the verge of bankruptcy. That showed me that Seaside is not investing in any company, they are simply in the business of buying shares in small companies at a discount, then turning around and selling the stock in the open market at a profit.
Clearly Seaside buys NNVC stock at 15% or more discount to market price. Then as long as they sell quickly, they should make a gain of at least 15%. The problem for a long time was that NNVC stock was constantly dropping in price. That meant that unless Seaside sold quickly they could make less than 15%. My estimate is that they never sold NNVC stock at a loss.
When I look at this scenario, my estimate is that Seaside sold 90 to 100% of the stock they have bought. So at most they hold 10% of what they bought, most likely none. We know for sure that they do not have more than 5% of outstanding stock, otherwise they would have to file with SEC. I do not think they will have much stock left to sell after May. Others here have estimated that Seaside has been unable to sell all the stock and still has a significant amount of stock left with them. All of us are just estimating how much stock is still with Seaside.
Seeker
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM